Cambridge and ISPA scientists create a tool to identify individuals at risk of developing different myeloid leukemias
Researchers have developed MN-predict, a platform that identifies individuals at high risk of acute myeloid leukemia and related cancers. The test requires a blood sample and can be used to design new treatments and prevent the development of these cancers.